Allspring Global Investments
NVO

Allspring Global Investments’s Novo Nordisk NVO Stock Holding History

Allspring Global Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
38,209
+7,465
+24% +$354K ﹤0.01% 1108
2025
Q4 		$1.61M Sell
30,744
-56,238
-65% -$2.88M ﹤0.01% 1067
2025
Q3 		$5.15M Sell
86,982
-7,570
-8% -$443K 0.01% 865
2025
Q2 		$6.6M Sell
94,552
-3,295
-3% -$224K 0.01% 822
2025
Q1 		$6.66M Buy
97,847
+76,994
+369% +$6.36M 0.01% 837
2024
Q4 		$1.83M Sell
20,853
-406,932
-95% -$44M ﹤0.01% 1161
2024
Q3 		$50.9M Buy
427,785
+99,945
+30% +$13.3M 0.08% 309
2024
Q2 		$46.8M Buy
327,840
+14,549
+5% +$1.93M 0.08% 319
2024
Q1 		$40.2M Buy
313,291
+33,463
+12% +$3.98M 0.06% 391
2023
Q4 		$28.9M Buy
279,828
+279,244
+47,816% +$27.6M 0.05% 467
2023
Q3 		$53.1K Hold
584
– – ﹤0.01% 2245
2023
Q2 		$47.3K Buy
+584
New +$47.7K ﹤0.01% 2306

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Allspring Global Investments's NVO Position: Q1 2026 in Review

Allspring Global Investments increased its Novo Nordisk (NVO) stake by 24% in Q1 2026, buying an estimated $354K and bringing the position to 38,209 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Allspring Global Investments first reported a position in NVO in Q2 2023 and has held it in 12 quarters since. The position peaked at $50.9M in Q3 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Allspring Global Investments held 38,209 shares of Novo Nordisk worth $1.39M as of Q1 2026.
  • Allspring Global Investments bought 7,465 Novo Nordisk shares in Q1 2026, an estimated $354K.
  • Novo Nordisk made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1108 holding.
  • Allspring Global Investments first reported a position in Novo Nordisk in Q2 2023 and has held it in 12 quarters since.
  • Allspring Global Investments's Novo Nordisk position peaked at $50.9M in Q3 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.